Profil
Daniel K.
Treiber is the founder of Recludix Pharma, Inc., founded in 2019, where the title held is Senior Vice President-Discovery Technology.
The current job is Chief Scientific Officer-Drug Discovery Services at Eurofins DiscoverX Corp., Inc. The education history includes undergraduate studies at Middlebury College.
Postes actifs de Daniel K. Treiber
| Sociétés | Poste | Début |
|---|---|---|
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Manufactures reagents, complete cell-based assay kits, profiling, and screening services | Directeur Technique/Scientifique/R&D | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Fondateur | 01/01/2019 |
Formation de Daniel K. Treiber
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Manufactures reagents, complete cell-based assay kits, profiling, and screening services | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
















